Biopharmaceutical company Antios Therapeutics names CEO successor

Gregory Mayes co-founded Engage Therapeutics and serves as its CEO from 2017 until it was acquired by UCB in June.

Gregory Mayes co-founded Engage Therapeutics and serves as its CEO from 2017 until it was acquired by UCB in June.

View Original Article Source